average monthly weight loss tirzepatide weight-loss study shows promising results average weight loss on tirzepatide

Founds clinicians, trained in obesity medicine, can help patients identify the root cause of their weight gain and personalize a prescription to target it

This medication mimics the action of naturally occurring GLP-1, a hormone released by the intestines in response to food intake

The FDA notes that about 100 million prescriptions or OTC purchases of both drugs combined were made in 2022

Understanding the relationship between GLP-1 therapy and skeletal health helps patients and clinicians make informed decisions whilst implementing strategies to protect bone integrity during treatment

For type 2 diabetes treatment, tirzepatide (Mounjaro) shows constipation rates of 12-17% across doses, while semaglutide (Ozempic) reports rates of 8-10% at diabetes doses